These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 29426286

  • 1. Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry - a prospectively controlled randomized double-blind clinical trial.
    Beiderlinden M, Werner P, Bahlmann A, Kemper J, Brezina T, Schäfer M, Görlinger K, Seidel H, Kienbaum P, Treschan TA.
    BMC Anesthesiol; 2018 Feb 09; 18(1):18. PubMed ID: 29426286
    [Abstract] [Full Text] [Related]

  • 2. Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial.
    Treschan TA, Schaefer MS, Geib J, Bahlmann A, Brezina T, Werner P, Golla E, Greinacher A, Pannen B, Kindgen-Milles D, Kienbaum P, Beiderlinden M.
    Crit Care; 2014 Oct 25; 18(5):588. PubMed ID: 25344113
    [Abstract] [Full Text] [Related]

  • 3. Monitoring of Argatroban and Lepirudin: What is the Input of Laboratory Values in "Real Life"?
    Seidel H, Kolde HJ.
    Clin Appl Thromb Hemost; 2018 Mar 25; 24(2):287-294. PubMed ID: 28320219
    [Abstract] [Full Text] [Related]

  • 4. An evaluation of monitoring possibilities of argatroban using rotational thromboelastometry and activated partial thromboplastin time.
    Engström M, Rundgren M, Schött U.
    Acta Anaesthesiol Scand; 2010 Jan 25; 54(1):86-91. PubMed ID: 19719819
    [Abstract] [Full Text] [Related]

  • 5. The influence of laboratory coagulation tests and clotting factor levels on Rotation Thromboelastometry (ROTEM(R)) during major surgery with hemorrhage.
    Theusinger OM, Schröder CM, Eismon J, Emmert MY, Seifert B, Spahn DR, Baulig W.
    Anesth Analg; 2013 Aug 25; 117(2):314-21. PubMed ID: 23780419
    [Abstract] [Full Text] [Related]

  • 6. Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing.
    Gosselin RC, King JH, Janatpour KA, Dager WE, Larkin EC, Owings JT.
    Ann Pharmacother; 2004 Sep 25; 38(9):1383-8. PubMed ID: 15238620
    [Abstract] [Full Text] [Related]

  • 7. Monitoring of anticoagulant effects of direct thrombin inhibitors.
    Fenyvesi T, Jörg I, Harenberg J.
    Semin Thromb Hemost; 2002 Aug 25; 28(4):361-8. PubMed ID: 12244483
    [Abstract] [Full Text] [Related]

  • 8. The use of ecarin chromogenic assay and prothrombinase induced clotting time in the monitoring of lepirudin for the treatment of heparin-induced thrombocytopenia.
    Guy S, Kitchen S, Laidlaw S, Cooper P, Woolley A, Maclean R.
    Br J Haematol; 2008 Jul 25; 142(3):466-8. PubMed ID: 18510685
    [Abstract] [Full Text] [Related]

  • 9. Lepirudin dose-dependently increases thrombelastography parameters at therapeutic plasma concentrations as measured with ROTEM® - a pilot study.
    Feuring M, Wehling M, Schultz A.
    Int J Clin Pharmacol Ther; 2011 Oct 25; 49(10):626-8. PubMed ID: 21961488
    [Abstract] [Full Text] [Related]

  • 10. Effect of phenprocoumon on monitoring of lepirudin, argatroban, melagatran and unfractionated heparin with the PiCT method.
    Fenyvesi T, Jörg I, Harenberg J.
    Pathophysiol Haemost Thromb; 2002 Oct 25; 32(4):174-9. PubMed ID: 12759518
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Monitoring of the anticoagulants argatroban and lepirudin: a comparison of laboratory methods.
    Ivandic B, Zorn M.
    Clin Appl Thromb Hemost; 2011 Oct 25; 17(5):549-55. PubMed ID: 20834029
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Argatroban and lepirudin requirements in a 6-year-old patient with heparin-induced thrombocytopenia.
    John TE, Hallisey RK.
    Pharmacotherapy; 2005 Oct 25; 25(10):1383-8. PubMed ID: 16185183
    [Abstract] [Full Text] [Related]

  • 16. Limitation of the activated partial thromboplastin time as a monitoring method of the direct thrombin inhibitor argatroban.
    Guy S, Kitchen S, Maclean R, Van Veen JJ.
    Int J Lab Hematol; 2015 Dec 25; 37(6):834-43. PubMed ID: 26305560
    [Abstract] [Full Text] [Related]

  • 17. Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban.
    Harenberg J, Jörg I, Fenyvesi T, Piazolo L.
    J Thromb Thrombolysis; 2005 Feb 25; 19(1):65-9. PubMed ID: 15976970
    [Abstract] [Full Text] [Related]

  • 18. Monitoring bivalirudin therapy in children on extracorporeal circulatory support devices: Thromboelastometry versus routine coagulation testing.
    Teruya J, Hensch L, Bruzdoski K, Adachi I, Hui SR, Kostousov V.
    Thromb Res; 2020 Feb 25; 186():54-57. PubMed ID: 31884000
    [Abstract] [Full Text] [Related]

  • 19. Collaborative study on monitoring methods to determine direct thrombin inhibitors lepirudin and argatroban.
    Gray E, Harenberg J, ISTH Control of Anticoagulation SSC Working Group on Thrombin Inhibitors.
    J Thromb Haemost; 2005 Sep 25; 3(9):2096-7. PubMed ID: 16102117
    [No Abstract] [Full Text] [Related]

  • 20. Heparin-Induced Thrombocytopenia in Infants after Heart Surgery.
    Abdillah JN, Hu Q, Chen X, Chen X, Zhou W, Luo W, Huang L.
    Thorac Cardiovasc Surg; 2019 Jan 25; 67(1):21-27. PubMed ID: 29605959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.